Efficacy and Safety of Shexiang Baoxin Pill(MUSKARDIA) in the Treatment of Acute Myocardial Infarction
NCT07153744 · Status: NOT_YET_RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 9588
Last updated 2025-09-04
Summary
This study aims to evaluate the value of Shexiang Baoxin Pill (MUSKARDIA) in patients with acute myocardial infarction (AMI) through a prospective, multicenter, pragmatic randomized controlled real-world study. It seeks to validate its efficacy in reducing cardiovascular event risk during the peri-PCI period, as well as its effects on cardiac function, quality of life , and relevant biomarkers. Through this research, we expect to provide higher-quality evidence for the application of SBP in AMI patients undergoing PCI, thereby further optimizing comprehensive treatment strategies for AMI.
Conditions
- Acute Myocardial Infarction (AMI)
- Percutaneous Coronary Intervention (PCI)
Interventions
- DRUG
-
Patients in the Shexiang Baoxin Pill(MUSKARDI) group initiated treatment immediately after randomization. They received 2-4 pills of Shexiang Baoxin Pill preoperatively before PCI, followed by a maintenance dose of 2-4 pills orally three times daily (TID) with warm water for 12 months postoperatively, concurrently with standard guideline-directed therapy.
- DRUG
-
Shexiang Baoxin Pill
Patients in the Shexiang Baoxin Pill group initiated treatment immediately after randomization. They received 2-4 pills of Shexiang Baoxin Pill preoperatively before PCI, followed by a maintenance dose of 2-4 pills orally three times daily (TID) with warm water for 12 months postoperatively, concurrently with standard guideline-directed therapy.
Sponsors & Collaborators
-
Shanghai Zhongshan Hospital
collaborator OTHER -
Huashan Hospital
collaborator OTHER -
Shanghai 10th People's Hospital
collaborator OTHER -
Shanghai 6th People's Hospital
collaborator OTHER -
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
collaborator OTHER -
Shanghai East Hospital
collaborator OTHER -
Longhua Hospital
collaborator OTHER -
Second Affiliated Hospital of Soochow University
collaborator OTHER -
Affiliated Hospital of Jiangsu University
collaborator OTHER -
The First Affiliated Hospital with Nanjing Medical University
collaborator OTHER -
The First People's Hospital of Lianyungang
collaborator OTHER -
Huai'an First People's Hospital
collaborator OTHER -
Sir Run Run Shaw Hospital
collaborator OTHER -
Second Affiliated Hospital, School of Medicine, Zhejiang University
collaborator OTHER -
First Affiliated Hospital of Ningbo University
collaborator NETWORK -
Shandong Provincial Hospital
collaborator OTHER_GOV -
Qianfoshan Hospital
collaborator OTHER -
Weihai Municipal Hospital
collaborator OTHER -
Weifang People's Hospital
collaborator OTHER -
Rizhao People's Hospital
collaborator OTHER -
The Affiliated Hospital of Qingdao University
collaborator OTHER -
Jining First People's Hospital
collaborator OTHER -
Linyi People's Hospital
collaborator OTHER -
Xiangya Hospital of Central South University
collaborator OTHER -
Second Xiangya Hospital of Central South University
collaborator OTHER -
Yueyang Central Hospital
collaborator OTHER -
The First Affiliated Hospital of University of South China
collaborator OTHER -
The Central Hospital of Shaoyang
collaborator UNKNOWN -
The First People's Hospital of Changde City
collaborator OTHER -
Wuxi People's Hospital
collaborator OTHER -
Jinhua Central Hospital
collaborator OTHER -
The Third Affiliated Hospital of Wenzhou Medical University
collaborator OTHER -
Shuguang Hospital of Shanghai University of Traditional Chinese Medicine
collaborator UNKNOWN -
Affiliated Hospital of Shandong University of Traditional Chinese Medicine
collaborator OTHER -
ZhuZhou Central Hospital
collaborator OTHER -
First People's Hospital of Chenzhou
collaborator OTHER -
People's Hospital of Quzhou
collaborator OTHER -
Xuzhou New Health Hospital
collaborator UNKNOWN -
Taizhou Enze Medical Center Group
collaborator OTHER -
Beijing Chao Yang Hospital
collaborator OTHER -
Civil Aviation General Hospital
collaborator OTHER -
Xuanwu Hospital, Beijing
collaborator OTHER -
Beijing Friendship Hospital
collaborator OTHER -
Peking University People's Hospital
collaborator OTHER -
Beijing Electric Power Hospital
collaborator OTHER -
Renmin Hospital of Wuhan University
collaborator OTHER -
Wuhan No.1 Hospital
collaborator OTHER -
Jingzhou Central Hospital
collaborator OTHER -
The First Affiliated Hospital of Dalian Medical University
collaborator OTHER -
Ansteel Group General Hospital
collaborator UNKNOWN -
General Hospital of Fuxin Mining Industry Group of Liaoning Health Industry Group
collaborator UNKNOWN -
The First Affiliated Hospital of Zhengzhou University
collaborator OTHER -
Huaihe Hospital of Henan University
collaborator OTHER -
Zhoukou Central Hospital
collaborator OTHER -
The First Affiliated Hospital of Henan University of Science and Technology
collaborator OTHER -
First Affiliated Hospital of Nanyang Medical College
collaborator OTHER -
Jiaozuo Second People's Hospital
collaborator UNKNOWN -
Anyang Area Hospital of Puyang City
collaborator UNKNOWN -
Shijiazhuang People's Hospital
collaborator OTHER -
Cangzhou Central Hospital
collaborator OTHER -
The First Hospital of Hebei Medical University
collaborator OTHER -
Handan Central Hospital
collaborator OTHER -
The People's Hospital of Langfang City
collaborator UNKNOWN -
Xingtai Central Hospital
collaborator UNKNOWN -
North China University of Science and Technology
collaborator OTHER -
The First Affiliated Hospital of Anhui Medical University
collaborator OTHER -
the First Hospital of Anhui University of Science and Technology
collaborator UNKNOWN -
Chaohu Hospital of Anhui Medical University
collaborator OTHER -
Tongling People's Hospital
collaborator OTHER_GOV -
Huang Shan People's Hospital
collaborator OTHER -
Huaibei Miners General Hospital
collaborator UNKNOWN -
The Second Affiliated Hospital of Fujian Medical University
collaborator OTHER -
Changzhi Medical College
collaborator OTHER -
LinFen People's Hospital
collaborator UNKNOWN -
Shanxi Cardiovascular Hospital
collaborator OTHER -
Dazhou First People's Hospital
collaborator UNKNOWN -
The Affiliated Hospital Of Southwest Medical University
collaborator OTHER -
The Third Affiliated Hospital of Guangzhou Medical University
collaborator OTHER -
The First Affiliated Hospital of Guangdong Pharmaceutical University
collaborator OTHER -
Yangchun People's Hospital
collaborator UNKNOWN -
Shaoguan People's Hospital
collaborator UNKNOWN -
Guilin People's Hospital
collaborator UNKNOWN -
The First Affiliated Hospital of Nanchang University
collaborator OTHER -
Ji'an Central People's Hospital
collaborator UNKNOWN -
Jiangxi Provincial People's Hopital
collaborator OTHER -
People's Hospital of Chongqing
collaborator OTHER -
Ankang Central Hospital
collaborator OTHER -
Xiangyang Central Hospital
collaborator OTHER -
Tianjin Third Central Hospital
collaborator OTHER -
General Hospital of Ningxia Medical University
collaborator OTHER -
The Second Affiliated Hospital of Hainan Medical University
collaborator OTHER -
Lanzhou University Second Hospital
collaborator OTHER -
Jilin Province People's Hospital
collaborator UNKNOWN -
Inner Mongolia Autonomous Region People's Hospital
collaborator UNKNOWN -
Yan'an Hospital of Kunming City
collaborator UNKNOWN -
The People's Hospital of Jizhou District, Tianjin
collaborator UNKNOWN -
The Southwest Hospital of Army Medical University
collaborator UNKNOWN -
The First People's Hospital of Nanning
collaborator UNKNOWN -
The People' s Hospital of Jiangmen
collaborator UNKNOWN -
The second People's Hospital of Guiyang
collaborator UNKNOWN -
The Third People's Hospital of Chengdu
collaborator OTHER -
The Tirst People's Hospital of Mianyang
collaborator UNKNOWN -
First Affiliated Hospital of Fujian Medical University
collaborator OTHER -
The First People's Hospital of Chu Zhou
collaborator UNKNOWN -
Xuancheng people's hospital
collaborator UNKNOWN -
Shanghai Hutchison Pharmaceuticals Limited
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-09-01
- Primary Completion
- 2028-12-31
- Completion
- 2029-12-31
Countries
- China
Study Locations
More Related Trials
-
Qishenyiqi for Ventricular Remodeling After Myocardial Infarction
NCT06699407 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Efficacy and Safety of Qishenyiqi Dripping Pills for Treating Chronic Heart Failure With Preserved Ejection Fraction
NCT04944706 ·Status: COMPLETED ·Phase: PHASE2
-
Study on the Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of SHR-2004 Injection in Adult Patients With Atrial Fibrillation
NCT06280768 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
A Study of HRS-5632 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular Events
NCT07185776 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Pharmacokinetics, Safety and Tolerability Study of Multiple Formulations of BMS-986231 in Healthy Participants
NCT03891108 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Continuous Infusions of HNO (Nitroxyl) Donor in Patients With Heart Failure and Impaired Systolic Function
NCT03357731 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Nivolumab vs Placebo in Patients With Acute Myocardial Infarction: A Randomized Clinical Trial
NCT05887830 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Combination of Daratumumab and BD Regimen and Dapagliflozin in the Treatment of M-protein Related Cardiac Disease
NCT06297681 ·Status: NOT_YET_RECRUITING
-
Study of Safety, Tolerability and Pharmacokinetics of Serelaxin in Japanese Acute Heart Failure (AHF) Patients
NCT02002702 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical and Metabonomics Study on the Treatment of Heart Failure After Myocardial Infarction With Modified Wenxin Decoction
NCT04667598 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study of Mavacamten in Obstructive Hypertrophic Cardiomyopathy
NCT05414175 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of BMS-986224 in Healthy Subjects and Heart Failure Patients With Reduced Ejection Fraction
NCT03281122 ·Status: TERMINATED ·Phase: PHASE1
-
Clinical Study on the Effect of Zhenyuan Capsule on Cardiopulmonary Function in Patients With SCAD
NCT04421287 ·Status: UNKNOWN ·Phase: PHASE4
-
The Pharmacokinetic Study of the Combination of Digoxin and Polythylene Glycol Loxenatide Injection in Healthy Subjects
NCT02451527 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of a Single Oral Dose of Moxidectin on the Cardiac QT Interval of Healthy Volunteers
NCT03012828 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of Xinyue Capsule in the Treatment of Heart Failure With Preserved Ejection Fraction
NCT06946095 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
A Clinical Study to Evaluate the Long-term Safety of HRS-1893 in Hypertrophic Cardiomyopathy
NCT07021963 ·Status: RECRUITING ·Phase: PHASE2
-
A Safety, Tolerability, Pharmacokinetic Study of SHR-6934 Injection in Healthy Subjects
NCT06700083 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Effect of Recombinant Human Brain Natriuretic Peptide on Ventricular Remodeling and Cardiac Function in Patients With Acute Anterior Myocardial Infraction Undergoing Percutaneous Coronary Intervention
NCT06463808 ·Status: RECRUITING
-
A Phase II Clinical Trial of HRS-1893 in the Treatment of Heart Failure With Preserved Ejection Fraction
NCT07269717 ·Status: RECRUITING ·Phase: PHASE2
-
Effect of BIA 5 1058 on Cardiac Repolarization
NCT03489005 ·Status: COMPLETED ·Phase: PHASE1
-
Registry Study of Pharmacotherapy and Clinical Outcomes in Elderly Patients With Coronary Heart Disease (PHARM-ageing)
NCT05246722 ·Status: NOT_YET_RECRUITING
-
Study Evaluating the Effects of MOA-728 on Cardiac Repolarization in Healthy Subjects
NCT00434395 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Vericiguat on Acute Coronary Syndrome( ACS)Patients With Ejection Fraction <45%
NCT06321094 ·Status: COMPLETED
-
The Modified "Pills-in-the-Pocket" Strategy
NCT06657404 ·Status: RECRUITING ·Phase: NA